Ending Soon! Save 33% on All Access

This Innovative Cap Helps Chemotherapy Patients Keep More Hair The FDA approved the DigniCap for use in the U.S. this week.

By Kim Lachance Shandrow

Opinions expressed by Entrepreneur contributors are their own.

Dignitana AB

Back in the big-hair '80s, my Auntie Mack had a thick, lush blonde bouffe. Then she got cancer. Chemo ruined her prized mane, leaving her bald and embarrassed. She chinned up, penciled on eyebrows and hid her scalp beneath a Harley Davidson bandana.

If ma tante had endured chemotherapy now, she might've kept her Dolly Parton "do. With a DigniCap on her head before and after radiation treatments, her hair could've had a good chance of staying put.

DigniCap is a silicon skull cap that's helping chemotherapy patients retain more hair. The chin-strapped head covering cools the scalp 30 minutes before and 90 minutes after chemotherapy.

Related: After Being Diagnosed With Cancer, This Entrepreneur Decided to Go Into Business With His Dad

The computer-controlled cap curbs blood flow to hair follicles so that less of the harsh, cancer-fighting chemicals reach hair cells. With the metabolism of the cells significantly decelerated, they receive a smaller dose of chemotherapy. This helps many DigniCap wearers keep more of their hair, along with their dignity, say the device's Swedish creators, Dignitana AB.

Related: Students Create Heroes App To Connect Cancer Patients And Survivors

"For many patients, the prospect of losing their hair is more than just a matter of vanity," a statement on DigniCap's website reads. "It's an unwelcome reminder of their disease for the patient and their families -- one that can negatively impact self-image, confidence and an overall sense of wellbeing."

Available outside of the U.S. for a couple of years now, the innovative cap was approved just this week by the FDA for use by breast cancer patients. The patented "cold cap," which costs hospitals and treatment centers between $1,500 and $3,000 each, has proven effective in half a dozen clinical studies. Of 122 women diagnosed with early-stage breast cancer who used it before and after chemotherapy, 70 percent retained more of their hair, UPI reports.

As for my Auntie Mack (nicknamed Mack after Mack Trucks, I kid you not), she beat cancer and her golden locks eventually grew back. Now, with a hint of silver at the roots, her hair's as big and bold as ever, just like her feisty biker mama spirit.

Related: 6 Hot Healthcare Companies: From Smart Pill Bottles to Smart Diapers, What's Driving Innovation in Medical Tech?

Kim Lachance Shandrow

Former West Coast Editor

Kim Lachance Shandrow is the former West Coast editor at Entrepreneur.com. Previously, she was a commerce columnist at Los Angeles CityBeat, a news producer at MSNBC and KNBC in Los Angeles and a frequent contributor to the Los Angeles Times. She has also written for Government Technology magazine, LA Yoga magazine, the Lowell Sun newspaper, HealthCentral.com, PsychCentral.com and the former U.S. Surgeon General, Dr. C. Everett Coop. Follow her on Twitter at @Lashandrow. You can also follow her on Facebook here

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Business News

Did OpenAI steal Scarlett Johansson's voice? 5 Critical Lessons for Entrepreneurs in The AI Era

Did OpenAI steal Scarlett Johansson's voice? OpenAI has since paused the "Sky" voice feature, but Johansson argues that this is no coincidence. In response, Johansson delivers a masterclass for entrepreneurs on navigating the AI era successfully.

Business News

Apple iPhone 7 Users May Be Owed a Slice of a $35 Million Settlement — Here's How to Claim Your Share

Previous (and current, no judgment) iPhone 7 users may be entitled to up to $349. The deadline to file a claim is June 3.

Business Ideas

63 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.

Innovation

How Corporate Investment Helps Startups Deploy Technology Faster Than Ever

Financial resources, strategic alignment, access to expertise, market validation and operational support make this deployment possible.